Glioblastoma Multiforme

Showing NaN - NaN of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

    Recruiting
    • Astrocytoma, Grade IV
    • +3 more
    • CYNK-001 systemic and Intra cavity administration
    • Duarte, California
    • +5 more
    Jan 20, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

    Recruiting
    • Glioblastoma Multiforme
    • Recurrent Glioblastoma
    • TheraSphere GBM
    • San Francisco, California
    • +4 more
    Aug 15, 2022

    Glioblastoma Multiforme, Brain Tumors Trial in United States (OncoGel (ReGel/Paclitaxel))

    Terminated
    • Glioblastoma Multiforme
    • Brain Neoplasms
    • OncoGel (ReGel/Paclitaxel)
    • Chicago, Illinois
    • +4 more
    Jun 2, 2022

    Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

    Active, not recruiting
    • Glioblastoma Multiforme
    • +6 more
    • Dendritic cell immunotherapy
    • Birmingham, Alabama
    • +85 more
    May 12, 2022

    Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

    Recruiting
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +17 more
    Apr 1, 2022

    Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)

    Completed
    • Glioblastoma Multiforme
    • Anaplastic Oligoastrocytoma
    • Los Angeles, California
    • +5 more
    Sep 21, 2021

    Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)

    Terminated
    • Glioblastoma Multiforme
    • Steroid eye drops
    • +6 more
    • Los Angeles, California
    • +21 more
    Mar 19, 2021

    Glioblastoma Multiforme Trial in United States (Bevacizumab and Temozolomide)

    Completed
    • Glioblastoma Multiforme
    • Bevacizumab and Temozolomide
    • Chicago, Illinois
    • +4 more
    Mar 5, 2021

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Chicago, Baltimore, Saint Paul (PAC-1 Compound)

    Suspended
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • PAC-1 Compound
    • Chicago, Illinois
    • +2 more
    Sep 18, 2020

    Glioblastoma Multiforme, Astrocytoma, Grade III, Anaplastic Ependymoma Trial in Chicago (biological, procedure, radiation)

    Terminated
    • Glioblastoma Multiforme
    • +4 more
    • Heat Shock Protein Peptide Complex-96 (HSPPC-96)
    • +2 more
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Jul 24, 2020

    Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

    Completed
    • Glioblastoma Multiforme
    • +3 more
    • Castro Valley, California
    • +16 more
    May 26, 2020

    Glioblastoma Multiforme Trial in United States (biological, drug, other)

    Completed
    • Glioblastoma Multiforme
    • bevacizumab
    • +2 more
    • Scottsdale, Arizona
    • +304 more
    Oct 4, 2019

    Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

    Completed
    • Glioblastoma Multiforme
    • Cilengitide 500 mg
    • Cilengitide 2000 mg
    • Birmingham, Alabama
    • +16 more
    Jan 18, 2019

    Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

    Suspended
    • Glioblastoma Multiforme
    • ICT-107
    • Placebo
    • Birmingham, Alabama
    • +64 more
    Aug 9, 2018

    Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

    Terminated
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +10 more
    Jan 30, 2018

    Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

    Completed
    • Adult Brain Glioblastoma
    • Glioblastoma Multiforme
    • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
    • Bevacizumab
    • Birmingham, Alabama
    • +15 more
    Jan 24, 2018

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (AdV-tk, Valacyclovir)

    Completed
    • Malignant Glioma
    • +2 more
    • Duarte, California
    • +3 more
    Apr 8, 2017

    Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)

    Completed
    • Glioblastoma Multiforme
    • Birmingham, Alabama
    • +88 more
    Apr 7, 2017

    Glioblastoma Multiforme Trial in United States (MEDI-575)

    Completed
    • Glioblastoma Multiforme
    • Tucson, Arizona
    • +11 more
    Feb 21, 2017

    Glioblastoma Multiforme Trial in United States (ICT-107, Placebo DC)

    Completed
    • Glioblastoma Multiforme
    • ICT-107
    • Placebo DC
    • South Birmingham, Alabama
    • +24 more
    Feb 10, 2017

    Brain Tumor, Recurrent, Glioblastoma Multiforme Trial in Chicago (Photon Radiosurgery System (Intrabeam))

    Completed
    • Brain Tumor, Recurrent
    • Glioblastoma Multiforme
    • Photon Radiosurgery System (Intrabeam)
    • Chicago, Illinois
      Children's Memorial Hospital
    Feb 27, 2015